Sandbox:Maneesha: Difference between revisions
Aditya Ganti (talk | contribs) (Replaced content with "__NOTOC__") Tag: Replaced |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
==Epidemiology and Demographics=== | |||
ncidence | |||
The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | |||
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | |||
Prevalence | |||
The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | |||
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | |||
The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | |||
Case-fatality rate/Mortality rate | |||
In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%. | |||
The case-fatality rate/mortality rate of [disease name] is approximately [number range]. | |||
Age | |||
Patients of all age groups may develop [disease name]. | |||
The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. | |||
[Disease name] commonly affects individuals younger than/older than [number of years] years of age. | |||
[Chronic disease name] is usually first diagnosed among [age group]. | |||
[Acute disease name] commonly affects [age group]. | |||
Race | |||
There is no racial predilection to [disease name]. | |||
[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | |||
Gender | |||
[Disease name] affects men and women equally. | |||
[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1. | |||
Region | |||
The majority of [disease name] cases are reported in [geographical region]. | |||
[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | |||
Developed Countries | |||
Developing Countries |
Revision as of 18:45, 8 January 2019
Epidemiology and Demographics=
ncidence The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. Prevalence The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. The prevalence of [disease/malignancy] is estimated to be [number] cases annually. Case-fatality rate/Mortality rate In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%. The case-fatality rate/mortality rate of [disease name] is approximately [number range]. Age Patients of all age groups may develop [disease name]. The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. [Disease name] commonly affects individuals younger than/older than [number of years] years of age. [Chronic disease name] is usually first diagnosed among [age group]. [Acute disease name] commonly affects [age group]. Race There is no racial predilection to [disease name]. [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. Gender [Disease name] affects men and women equally. [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1. Region The majority of [disease name] cases are reported in [geographical region]. [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. Developed Countries Developing Countries